The $63.7 Billion Opportunity in Precision Oncology
The oncology biomarker diagnostics market is entering a decade of exponential growth, projected to reach USD 63.71 billion by 2030 at a 13.9 % CAGR. From AI-driven liquid biopsies to multi-omic profiling and companion diagnostics, a new era of data-enabled precision medicine is here.
But with over 200 competitors already in play, the defining question remains:
Will your organization lead this transformation or be shaped by it?
Inside the Executive Whitepaper
Frost & Sullivan’s latest leadership brief, “Growth Opportunities in Oncology Biomarker Diagnostics,” reveals how innovators are redefining the future of cancer care through technology convergence and ecosystem integration.
Why Download This Whitepaper
-
-
-
Identify where to invest across the oncology diagnostics value chain.
-
Translate innovation into actionable enterprise strategy
-
Benchmark your organization against global transformation leaders.
-
Prepare your 2026 growth roadmap with data-driven foresight.
-
-
Explore the Full Whitepaper
What You’ll Learn
-
-
-
Market Momentum: Explore how AI, genomics, and informatics are fueling double-digit global growth across North America, Europe, APAC, and MENASA.
-
Competitive Dynamics: Understand how industry leaders such as Roche, Thermo Fisher, Illumina, and Agilent are leveraging partnerships, M&A, and digital ecosystems to sustain advantage.
-
Emerging Growth Opportunities:
-
-
Next-gen Predictive Biomarkers driving personalized immunotherapy outcomes.
-
Comprehensive genomic profiling (CGP) enabling real-time treatment optimization.
-
-
-
Leadership Imperatives: The strategic questions every executive must answer to capture market share and accelerate value-based care.
-
Visionary Growth Framework: Apply Frost & Sullivan’s Visionary Growth Pipeline to align innovation, transformation, and ROI.
-
-
Lead the Precision Revolution
Now is the time to convert insight into enterprise action. Download the executive whitepaper to discover how to unlock new value across diagnostics, pharma, and personalized oncology care.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on store.frost.com.
*$1,000 honorarium is subject to eligibility
